These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8251104)

  • 1. The pipeline for antiepileptic drugs.
    McKelvy JF
    Epilepsy Res Suppl; 1993; 10():3-8. PubMed ID: 8251104
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiepileptic drugs: future development.
    Porter RJ
    Epilepsy Res Suppl; 1993; 10():69-77. PubMed ID: 7504494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical testing.
    Cereghino JJ; Kupferberg HJ
    Epilepsy Res Suppl; 1993; 10():19-30. PubMed ID: 8251096
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational basis for the development of new antiepileptic drugs.
    Mutani R; Cantello R; Gianelli M; Bettucci D
    Epilepsy Res Suppl; 1991; 3():23-8. PubMed ID: 1685649
    [No Abstract]   [Full Text] [Related]  

  • 5. The brain distribution of old and new antiepileptic drugs.
    Monaco F; Sechi G
    Epilepsy Res Suppl; 1991; 3():57-65. PubMed ID: 1777083
    [No Abstract]   [Full Text] [Related]  

  • 6. Applications of computer assisted quantum pharmacology calculations in devising anticonvulsant rational polypharmacy strategies.
    Weaver DF
    Epilepsy Res Suppl; 1996; 11():95-111. PubMed ID: 9294731
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of polypharmacy: prediction of drug interactions.
    Mather GG; Levy RH
    Epilepsy Res Suppl; 1996; 11():113-21. PubMed ID: 9294732
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of animal models in developing guiding principles for polypharmacy in epilepsy.
    Löscher W; Wauquier A
    Epilepsy Res Suppl; 1996; 11():61-5. PubMed ID: 9294728
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurobiology as a basis for rational polypharmacy. Section overview for rational polypharmacy conference.
    Lothman EW
    Epilepsy Res Suppl; 1996; 11():3-7. PubMed ID: 9294724
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroprotective activity of antiepileptic drugs].
    Czuczwar K; Czuczwar M; Cieszczyk J; Gawlik P; Luszczki JJ; Borowicz KK; Czuczwar SJ
    Przegl Lek; 2004; 61(11):1268-71. PubMed ID: 15727029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy.
    Löscher W; Ebert U
    Epilepsy Res Suppl; 1996; 11():17-43. PubMed ID: 9294726
    [No Abstract]   [Full Text] [Related]  

  • 13. Old and new mechanisms of antiepileptic drug actions.
    Dichter MA
    Epilepsy Res Suppl; 1993; 10():9-17. PubMed ID: 8251108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antiepileptic drugs: new therapeutic options].
    Baulac M
    Rev Neurol (Paris); 2002 May; 158(5 Pt 2):4S46-54. PubMed ID: 11997751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
    Pollard JR
    Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol.
    Vincent JC
    Epilepsy Res Suppl; 1991; 3():153-6. PubMed ID: 1777073
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular structures of anticonvulsants: molecular neurobiology of epilepsy].
    Böhme I; Lüddens H
    Pharm Unserer Zeit; 2007; 36(4):262-8. PubMed ID: 17623315
    [No Abstract]   [Full Text] [Related]  

  • 18. Is tolerance to antiepileptic drugs clinically relevant?
    Avanzini G
    Epilepsia; 2006 Aug; 47(8):1285-7. PubMed ID: 16922871
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
    Browne TR
    Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
    [No Abstract]   [Full Text] [Related]  

  • 20. Ralitoline.
    Anhut H; Satzinger G; von Hodenberg A
    Epilepsy Res Suppl; 1991; 3():141-5. PubMed ID: 1777070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.